Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Royal Adelaide Hospital |
---|---|
Information provided by: | Royal Adelaide Hospital |
ClinicalTrials.gov Identifier: | NCT00124761 |
This study examines surgery versus radiosurgery (highly focussed radiation) for the treatment of cancer which has spread to one spot in the brain (solitary brain “metastasis”). For these two treatment options, it will compare patients’ survival times, quality of life, control rate of the brain metastases and side effects. It uses the most rigorous scientific method available called “randomisation” which minimises biases that exist with other types of studies. It will involve 30 – 40 patients.
Condition | Intervention | Phase |
---|---|---|
Neoplasm Metastasis Brain Neoplasm |
Procedure: Radiosurgery (compared with surgery) |
Phase III |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Open Label, Active Control, Parallel Assignment, Safety/Efficacy Study |
Official Title: | A Randomised Trial of Surgery Plus Whole Brain Radiotherapy (WBRT) Versus Radiosurgery Plus WBRT for Solitary Brain Metastases |
Estimated Enrollment: | 40 |
Study Start Date: | December 2002 |
Primary objectives – to evaluate for solitary brain metastases whether both overall survival and health related quality of life (HQoL) in patients treated with radiosurgery (RS) plus whole brain radiotherapy (WBRT) are non-inferior to those of patients treated with surgery (S) plus WBRT.
Secondary objectives – to compare between the two treatment arms time to local and distant brain recurrence, failure free survival, acute and late toxicity.
Hypothesis – Patients treated with RS + WBRT have neither worse survival nor worse quality of life than those treated with S + WBRT.
Research plan:
Outcomes and Significance:
The trial will enable Level I evidence to be applied to this common clinical problem. Patients will be able to make an informed choice based upon valid survival, quality of life and toxicity comparisons.
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion:
Contact: Daniel Roos, FRANZCR | +61 8 8222 4000 |
Australia, South Australia | |
Royal Adelaide Hospital | Recruiting |
Adelaide, South Australia, Australia, 5000 | |
Contact: Daniel Roos, FRANZCR +61 8 8222 4000 | |
Principal Investigator: Daniel Roos, FRANZCR |
Study Chair: | Daniel Roos, FRANZCR | Royal Adelaide Hospital |
Study ID Numbers: | 021108 |
Study First Received: | July 27, 2005 |
Last Updated: | February 10, 2006 |
ClinicalTrials.gov Identifier: | NCT00124761 |
Health Authority: | Australia: Human Research Ethics Committee |
Radiosurgery Brain metastases Whole Brain Radiotherapy |
Neurosurgery Solitary Brain Metastases Adult Tumours Metastatic to Brain |
Brain Neoplasms Neoplasm Metastasis Central Nervous System Diseases |
Central Nervous System Neoplasms Brain Diseases Nervous System Neoplasms |
Neoplastic Processes Neoplasms Pathologic Processes Neoplasms by Site Nervous System Diseases |